ArticleEuropean radiology2026
Habitat imaging based on enhanced CT for predicting occult central lymph node metastasis in papillary thyroid carcinoma.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesThis study aimed to develop a combined model based on clinical, intratumoral habitat, and peritumoral radiomic features to predict occult central lymph node metastasis (OCLNM) in patients with papillary thyroid carcinoma (PTC). MATERIALS AND
methodsThis retrospective study analysed preoperative enhanced CT images and clinical parameters from 219 PTC patients from two medical centers. The patients were divided into a training cohort from Center 1 (n = 154) and an external validation cohort from Center 2 (n = 65). Habitat radiomics features from the tumor and 3-mm peritumoral region were extracted from both arterial phase (AP) and venous phase (VP) CT images, respectively. Five machine learning (ML) methods were employed to construct models. The area under the curve (AUC) was used to evaluate the model performance, thereby selecting the best-performing ML model. Ultimately, a combined model was developed by integrating clinical factors with the optimal AP and VP habitat models.
resultsAge, TSH, and PLT were identified as independent predictors. Both the intratumoral habitat and peritumoral radiomics models based on LR exhibited excellent performance in the training and external validation cohorts (AUC: 0.820 and 0.805 in AP; 0.884 and 0.850 in VP). The combined model demonstrated superior predictive capability, achieving AUCs of 0.932 in the training cohort and 0.878 in the external validation cohort.
conclusionThe combined model integrating intratumoral habitat and peritumoral radiomics from enhanced CT images with clinical features provides a potential, non-invasive preoperative method for predicting OCLNM in PTC patients and may provide supplementary information for preoperative risk stratification. KEY POINTS: Question Accurate preoperative diagnosis of OCLNM in PTC is crucial for guiding dissection but remains an urgent clinical challenge. Findings A combined model integrating CT-based intratumoral habitats, peritumoral radiomics, and clinical factors achieved superior performance (AUC: 0.878) in predicting occult metastases across two centers. Clinical relevance This non-invasive model may serve as an adjunctive tool for preoperative risk stratification, providing supplementary information to support individualized surgical planning in patients with PTC.
Indexed as
Identifiers
42763332What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.